πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

3,061 results for β€œBio” Clear

  1. Behavioral Drug and HIV Risk Reduction Counseling

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate Dependence

    phase 3 other completed

    1 trial

  2. Bel-sar

    Aura Biosciences

    Choroidal Melanoma

    phase 3 small molecule active

    1 trial

  3. Bendamustine 100 mg Powder for concentrate for Solution for Infusion, Truxima 100 mg concentrate for solution for infusion, RoActemra 20 mg/mL concentrate for solution for infusion, PREDNISONE BIOGARAN 20 mg, scored tablet, Cyclophosphamide Injection 500 mg., Doxorubicin 2 mg/ml Solution for Injection., Truxima 500 mg concentrate for solution for infusion, Vincristine Sulfate 1 mg/ml solution for injection, Revlimid 5 mg hard capsules, Epcoritamab (GEN3013), Epcoritamab (GEN3013), Revlimid 20 mg hard capsul

    AbbVie Deutschland GmbH & Co. KG

    Follicular Lymphoma

    phase 3 small molecule active

    1 trial

  4. Bevacizumab

    Samsung Bioepis NL B.V.

    Lung Cancer

    phase 3 small molecule completed

    1 trial

  5. Bias retraining

    BRIGHT MINDS BIOSCIENCES INC.

    Alcohol Use Disorder

    phase 3 other completed

    1 trial

  6. BioFoam Surgical Matrix

    United Therapeutics Europe Ltd

    Intraoperative Bleeding

    phase 3 other terminated

    1 trial

  7. Biological Therapies Sodium Ascorbate Solution 30 g in 100 mL Injection, SODIUM CHLORIDE

    Pari Pharma GmbH

    Patient with sepsis complicated by ARDS

    phase 3 small molecule active

    1 trial

  8. Biological/Vaccine

    Vertex Pharmaceuticals (Australia) Pty.

    Type 1 Diabetes

    phase 3 mab active

    1 trial

  9. Bion 1301/FUB523

    Novartis Pharmaceuticals

    IgA nephropathy

    phase 3 small molecule active

    1 trial

  10. Biosteron, 10 mg, tabletki, Senaxa PR, 2 mg, tabletki o przedΕ‚uΕΌonym uwalnianiu

    Lacuna Pharma Pty Ltd

    Menopause, sleep disorders in the postmenopausal period

    phase 3 small molecule active

    1 trial

  11. Booster Sessions

    BRIGHT MINDS BIOSCIENCES INC.

    Skill Development of Staff

    phase 3 other completed

    1 trial

  12. Brief Strategic Family Therapy (BSFT)

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Abuse

    phase 3 other completed

    1 trial

  13. Brief advice

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Abuse

    phase 3 other completed

    1 trial

  14. Brief motivational intervention

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Use

    phase 3 other completed

    1 trial

  15. Buprenorphine

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Dependence

    phase 3 small molecule completed

    2 trials

  16. Buprenorphine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    phase 3 small molecule completed

    5 trials

  17. Buprenorphine

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-use Disorder

    phase 3 small molecule active

    1 trial

  18. Buprenorphine + Naltrexone

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 3 small molecule completed

    1 trial

  19. Buprenorphine +OTP

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Addiction

    phase 3 small molecule completed

    1 trial

  20. Buprenorphine Injection

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-Related Disorders

    phase 3 small molecule completed

    1 trial

  21. Buprenorphine/Naloxone

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    phase 3 small molecule terminated

    1 trial

  22. Buprenorphine/naloxone

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Dependence

    phase 3 small molecule completed

    2 trials

  23. Buprenorphine/naloxone

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-Related Disorders

    phase 3 small molecule terminated

    6 trials

  24. Bupropion

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 3 small molecule active

    3 trials

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources